Active Ingredient: BOSENTAN
Proprietary Name: BOSENTAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 62.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210342
Product Number: 001
Approval Date: Jan 3, 2020
Applicant Holder Full Name: CHARTWELL MOLECULAR HOLDINGS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information